Publications (2)0.6 Total impact
-
Article: Rosuvastatin zur Primärprävention vaskulärer Komplikationen
Der Internist 04/2012; 51(1):103-106. · 0.30 Impact Factor -
Article: [Rosuvastatin for primary prevention of vascular events : JUPITER trial (Justification for the Use of statins in Prevention: an Intervention Trial Evaluation Rosuvastatin).]
Der Internist 01/2010; 51(1):103-106. · 0.30 Impact Factor
Top Journals
- Der Internist (1)
- Der Internist (1)
Institutions
-
2010
-
Gesundheit Nord - Bremen Hospital Group
Bremen, Bremen, Germany
-